Can topical diclofenac cause tinnitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Topical Diclofenac and Tinnitus Risk

Topical diclofenac is highly unlikely to cause tinnitus due to minimal systemic absorption, though oral NSAIDs including diclofenac have been associated with tinnitus risk.

Evidence from Guidelines and Drug Labels

The FDA drug label for topical diclofenac does not list tinnitus as an adverse effect 1. Multiple clinical practice guidelines recommend topical diclofenac as a first-line treatment specifically because of its favorable safety profile compared to oral NSAIDs, with emphasis on minimal systemic absorption 2, 3. The 2019 EULAR guidelines note that pooled safety data from randomized trials comparing topical diclofenac gel with placebo showed "similar low rates of adverse effects" even in high-risk patients 2.

The 2021 VA/DoD guidelines for osteoarthritis management found topical diclofenac to be "superior to placebo and equivalent to oral diclofenac at reducing pain" but with "markedly fewer gastrointestinal adverse events" and only "substantially more local adverse events" (skin reactions at application site) 3. Notably, ototoxicity is not mentioned as a concern with topical formulations.

Oral NSAIDs and Tinnitus: The Real Concern

The distinction between topical and oral formulations is critical. Oral diclofenac has documented associations with tinnitus, particularly with chronic use. A 1988 comparative trial found that significantly more patients discontinued oral diclofenac compared to aspirin due to side effects, with tinnitus and deafness being primary reasons in the aspirin group 4.

A 2022 longitudinal study of 69,455 women found that frequent NSAID use (4-7 days/week) was associated with higher risk of incident persistent tinnitus, with hazard ratios of 1.17 for 4-5 days/week and 1.07 for 6-7 days/week 5. This study examined systemic NSAID exposure, not topical formulations.

Mechanism and Systemic Absorption

The pharmacokinetic profile explains the safety difference. After topical diclofenac application (40 mg/knee every 12 hours), mean steady-state plasma concentrations reach only 25.24 ng/mL 1. This represents minimal systemic exposure compared to oral administration. NSAIDs can cause ototoxicity through impairment of outer hair cell active processes and effects on peripheral and central auditory neurons 6, but these mechanisms require systemic drug levels.

Critical Caveat: Otic Administration

One important exception exists: A 2017 experimental study in guinea pigs found that topical diclofenac sodium administered directly as otic drops (into the middle ear through myringotomy) was as ototoxic as gentamicin, causing significant threshold elevation at all frequencies 7. This finding is relevant only for direct otic application in patients with tympanic membrane perforation, not for standard topical application to intact skin for musculoskeletal conditions.

Clinical Bottom Line

For standard dermatologic or musculoskeletal topical application to intact skin:

  • Tinnitus risk is negligible due to minimal systemic absorption
  • Local skin reactions (erythema, pruritus) are the primary adverse effects
  • Guidelines consistently recommend topical over oral NSAIDs specifically to avoid systemic adverse effects

Avoid topical diclofenac only if:

  • Patient has tympanic membrane perforation and the medication could enter the middle ear
  • Patient is using concurrent high-dose oral NSAIDs (additive systemic exposure)

If a patient develops tinnitus while using topical diclofenac, investigate other causes first (concurrent oral NSAIDs, aspirin, acetaminophen, aminoglycosides, or other ototoxic medications) 5, 8. The temporal relationship and systemic drug exposure make topical diclofenac an unlikely culprit.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.